What's in Inotek Pharmaceuticals Corporation's pipeline?

Inotek Pharmaceuticals Corporation has 8 drugs in our index: 1 marketed, 0 filed, 4 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Inotek Pharmaceuticals Corporation's portfolio?

Top competitors by shared drug class: Lokien van Nunen, Pfizer Inc., Trygg Pharma, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/inotek-pharmaceuticals-corporation.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Inotek Pharmaceuticals Corporation — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Inotek Pharmaceuticals Corporation pipeline: 1 marketed, 0 filed, 4 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 4 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
placebo BID	placebo BID	marketed
trabodenoson 6.0% QD	trabodenoson 6.0% QD	phase 3	Adenosine A1 receptor agonist	Adenosine A1 receptor	Ophthalmology
trabodenoson 3.0% QD	trabodenoson 3.0% QD	phase 3	Adenosine A1 receptor agonist	Adenosine A1 receptor	Ophthalmology
timolol 0.5% BID	timolol 0.5% BID	phase 3	Non-selective beta-adrenergic receptor blocker	Beta-adrenergic receptors	Ophthalmology
trabodenoson 4.5% BID	trabodenoson 4.5% BID	phase 3	Adenosine receptor agonist	A1 adenosine receptor	Ophthalmology

Therapeutic area mix

Ophthalmology · 4

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Lokien van Nunen · 1 shared drug class
Pfizer Inc. · 1 shared drug class
Trygg Pharma, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Inotek Pharmaceuticals Corporation:

Cite this brief

Drug Landscape (2026). Inotek Pharmaceuticals Corporation — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/inotek-pharmaceuticals-corporation. Accessed 2026-05-17.